All Stories

  1. Anticancer, anti-inflammatory and antioxidant potential of Schiff base-functionalized 1,2-benzothiazine derivatives

    Article • Journal of Molecular Structure, December 2025, Elsevier

    Dr Muhammad Hanif

  2. From Dimers to Tetramers in Copper(I) Triazene Complexes: Structural Insights and Catalytic Implications

    Article • November 2025, American Chemical Society (ACS)

    Dr Muhammad Hanif

  3. Copper Depletion in Tumors Boosts Immunotherapy

    Article • ChemBioChem, February 2025, Wiley

    Dr Muhammad Hanif

  4. Balancing Activity and Selectivity in Two‐Electron Oxygen Reduction through First Coordination Shell Engineering in Cobalt Single Atom Catalysts

    Article • Angewandte Chemie, January 2025, Wiley

    Dr Muhammad Hanif

  5. Harnessing metal complexes to target tumour bioenergetics and metabolic vulnerabilities

    Article • Inorganic Chemistry Frontiers, January 2025, Royal Society of Chemistry

    Dr Muhammad Hanif

  6. A Dual Action Platinum(IV) Complex with Self‐assembly Property Inhibits Prostate Cancer through Mitochondrial Stress Pathway

    Article • ChemMedChem, October 2024, Wiley

    Dr Muhammad Hanif

  7. Beyond cisplatin: New frontiers in metallodrugs for hard-to-treat triple negative breast cancer

    Article • Coordination Chemistry Reviews, January 2024, Elsevier

    Dr Muhammad Hanif

  8. Anticancer Ru and Os complexes of N-(4-chlorophenyl)pyridine-2-carbothioamide: Substitution of the labile chlorido ligand with phosphines

    Article • Journal of Inorganic Biochemistry, April 2023, Elsevier

    Dr Muhammad Hanif

  9. Platinum(terpyridine) complexes with N-heterocyclic carbene co-ligands: high antiproliferative activity and low toxicityin vivo

    Article • Dalton Transactions, January 2023, Royal Society of Chemistry

    Dr Muhammad Hanif

  10. Impact of Coordination Mode and Ferrocene Functionalization on the Anticancer Activity of N-Heterocyclic Carbene Half-Sandwich Complexes

    Article • Inorganic Chemistry, October 2022, American Chemical Society (ACS)

    Dr Muhammad Hanif

  11. Metal-Based Complexes in Cancer Treatment

    Article • Biomedicines, October 2022, MDPI AG

    Dr Muhammad Hanif

  12. Triazolyl- vs Pyridyl-Functionalized N-Heterocyclic Carbene Complexes: Impact of the Pendant N-Donor Ligand on Intramolecular C–C Bond Formation

    Article • ACS Organic & Inorganic Au, September 2022, American Chemical Society (ACS)

    Dr Muhammad Hanif

  13. Hydroxypyrone derivatives in drug discovery: from chelation therapy to rational design of metalloenzyme inhibitors

    Article • RSC Medicinal Chemistry, January 2022, Royal Society of Chemistry

    Dr Muhammad Hanif

  14. Antibacterial metal complexes of o ‐sulfamoylbenzoic acid: Synthesis, characterization, and DFT study

    Article • Applied Organometallic Chemistry, October 2021, Wiley

    Dr Muhammad Hanif

  15. Anti-Proliferative, Anti-Angiogenic and Safety Profiles of Novel HDAC Inhibitors for the Treatment of Metastatic Castration-Resistant Prostate Cancer

    Article • Pharmaceuticals, October 2021, MDPI AG

    Dr Muhammad Hanif

  16. Design concepts of half-sandwich organoruthenium anticancer agents based on bidentate bioactive ligands

    Article • Coordination Chemistry Reviews, October 2021, Elsevier

    Dr Muhammad Hanif

  17. Anthracenyl Functionalization of Half-Sandwich Carbene Complexes: In Vitro Anticancer Activity and Reactions with Biomolecules

    Article • Inorganic Chemistry, September 2021, American Chemical Society (ACS)

    Dr Muhammad Hanif

  18. Triazolyl‐Functionalized N‐Heterocyclic Carbene Half‐Sandwich Compounds: Coordination Mode, Reactivity and in vitro Anticancer Activity

    Article • ChemMedChem, July 2021, Wiley

    Dr Muhammad Hanif

  19. Monodentately-coordinated bioactive moieties in multimodal half-sandwich organoruthenium anticancer agents

    Article • Coordination Chemistry Reviews, July 2021, Elsevier

    Dr Muhammad Hanif

  20. Carbon Monoxide is an Inhibitor of HIF Prolyl Hydroxylase Domain 2

    Article • ChemBioChem, June 2021, Wiley

    Dr Muhammad Hanif

  21. Heptadentate, Octadentate, Or Even Nonadentate? Denticity in the Unexpected Formation of an All-Carbon Donor-Atom Ligand in RhIII(Cp*)(Anthracenyl-NHC) Complexes

    Article • Inorganic Chemistry, June 2021, American Chemical Society (ACS)

    Dr Muhammad Hanif

  22. An account of strategies and innovations for teaching chemistry during the COVID‐19 pandemic

    Article • Biochemistry and Molecular Biology Education, April 2021, Wiley

    Dr Muhammad Hanif

  23. Impact of the Metal Center and Leaving Group on the Anticancer Activity of Organometallic Complexes of Pyridine-2-carbothioamide

    Article • Molecules, February 2021, MDPI AG

    Dr Muhammad Hanif

  24. Cytostatic Action of Novel Histone Deacetylase Inhibitors in Androgen Receptor-Null Prostate Cancer Cells

    Article • Pharmaceuticals, January 2021, MDPI AG

    Dr Muhammad Hanif

  25. High Antiproliferative Activity of Hydroxythiopyridones over Hydroxypyridones and Their Organoruthenium Complexes

    Article • Biomedicines, January 2021, MDPI AG

    Dr Muhammad Hanif

  26. Mustards-Derived Terpyridine–Platinum Complexes as Anticancer Agents: DNA Alkylation vs Coordination

    Article • Inorganic Chemistry, January 2021, American Chemical Society (ACS)

    Dr Muhammad Hanif

  27. Tracing the anticancer compound [RuII(η6-p-cymene)(8-oxyquinolinato)Cl] in a biological environment by mass spectrometric methods

    Article • Analytical Methods, January 2021, Royal Society of Chemistry

    Dr Muhammad Hanif

  28. Breaking the Intracellular Redox Balance with Diselenium Nanoparticles for Maximizing Chemotherapy Efficacy on Patient-Derived Xenograft Models

    Article • ACS Nano, December 2020, American Chemical Society (ACS)

    Dr Muhammad Hanif

  29. Metal-Dependent Cytotoxic and Kinesin Spindle Protein Inhibitory Activity of Ru, Os, Rh, and Ir Half-Sandwich Complexes of Ispinesib-Derived Ligands

    Article • Inorganic Chemistry, October 2020, American Chemical Society (ACS)

    Dr Muhammad Hanif

  30. Thiourea-Derived Chelating Ligands and Their Organometallic Compounds: Investigations into Their Anticancer Activity

    Article • Molecules, August 2020, MDPI AG

    Dr Muhammad Hanif

  31. A Multitargeted Approach: Organorhodium Anticancer Agent Based on Vorinostat as a Potent Histone Deacetylase Inhibitor

    Article • Angewandte Chemie, June 2020, Wiley

    Dr Muhammad Hanif

  32. A Multitargeted Approach: Organorhodium Anticancer Agent Based on Vorinostat as a Potent Histone Deacetylase Inhibitor

    Article • Angewandte Chemie, June 2020, Wiley

    Dr Muhammad Hanif

  33. Heteroleptic Ruthenium(II) Complexes with Bathophenanthroline and Bathophenanthroline Disulfonate Disodium Salt as Fluorescent Dyes for In-Gel Protein Staining

    Article • Inorganic Chemistry, March 2020, American Chemical Society (ACS)

    Dr Muhammad Hanif

  34. Potent Inhibition of Thioredoxin Reductase by the Rh Derivatives of Anticancer M(arene/Cp*)(NHC)Cl2Complexes

    Article • Inorganic Chemistry, February 2020, American Chemical Society (ACS)

    Dr Muhammad Hanif

  35. Understanding Failure and Improving Treatment Using HDAC Inhibitors for Prostate Cancer

    Article • Biomedicines, January 2020, MDPI AG

    Dr Muhammad Hanif

  36. Synthesis, structure and fluxionality of Co(III) complexes containing chelated sulfate

    Article • Polyhedron, January 2020, Elsevier

    Dr Muhammad Hanif

  37. Design of organoruthenium complexes for nanoparticle functionalization

    Article • Journal of Organometallic Chemistry, April 2019, Elsevier

    Dr Muhammad Hanif

  38. Comparative solution studies and cytotoxicity of gallium(III) and iron(III) complexes of 3-hydroxy-2(1H)-pyridinones

    Article • Polyhedron, April 2019, Elsevier

    Dr Muhammad Hanif

  39. Periodic DFT modeling and vibrational analysis of silver(I) cyanide complexes of thioureas

    Article • Journal of Molecular Modeling, March 2019, Springer Science + Business Media

    Dr Muhammad Hanif

  40. Coordination Chemistry of Organoruthenium Compounds with Benzoylthiourea Ligands and their Biological Properties

    Article • Chemistry - An Asian Journal, February 2019, Wiley

    Dr Muhammad Hanif

  41. Structural Modifications of the Antiinflammatory Oxicam Scaffold and Preparation of Anticancer Organometallic Compounds

    Article • Organometallics, January 2019, American Chemical Society (ACS)

    Dr Muhammad Hanif

  42. Anticancer organorhodium and -iridium complexes with low toxicity in vivo but high potency in vitro: DNA damage, reactive oxygen species formation, and haemolytic activity

    Article • Chemical Communications, January 2019, Royal Society of Chemistry

    Dr Muhammad Hanif

  43. Synthesis, characterisation and electronic properties of naphthalene bridged disilanes

    Article • Dalton Transactions, January 2019, Royal Society of Chemistry

    Dr Muhammad Hanif

  44. Correction to “(Pyridin-2-yl)-NHC Organoruthenium Complexes: Antiproliferative Properties and Reactivity Toward Biomolecules”

    Article • Organometallics, October 2018, American Chemical Society (ACS)

    Dr Muhammad Hanif

  45. Hybrid compounds from chalcone and 1,2-benzothiazine pharmacophores as selective inhibitors of alkaline phosphatase isozymes

    Article • European Journal of Medicinal Chemistry, September 2018, Elsevier

    Prof. Dr. Abdullah M. Asiri, Dr Muhammad Hanif

  46. Understanding the interactions of diruthenium anticancer agents with amino acids

    Article • JBIC Journal of Biological Inorganic Chemistry, July 2018, Springer Science + Business Media

    Dr Muhammad Hanif

  47. A Bioactive l-Phenylalanine-Derived Arene in Multitargeted Organoruthenium Compounds: Impact on the Antiproliferative Activity and Mode of Action

    Article • Inorganic Chemistry, June 2018, American Chemical Society (ACS)

    Dr Muhammad Hanif

  48. Organoruthenium and -osmium Complexes of 2-Pyridinecarbothioamides Functionalized with a Sulfonamide motif: Synthesis, Cytotoxicity and Biomolecule Interaction

    Article • ChemPlusChem, May 2018, Wiley

    Dr Muhammad Hanif

  49. (Pyridin-2-yl)-NHC Organoruthenium Complexes: Antiproliferative Properties and Reactivity toward Biomolecules

    Article • Organometallics, May 2018, American Chemical Society (ACS)

    Dr Muhammad Hanif

  50. Rollover Cyclometalated Bipyridine Platinum Complexes as Potent Anticancer Agents: Impact of the Ancillary Ligands on the Mode of Action

    Article • Inorganic Chemistry, February 2018, American Chemical Society (ACS)

    Dr Muhammad Hanif

  51. Anticancer metallodrugs: where is the next cisplatin?

    Article • Future Medicinal Chemistry, February 2018, Future Science

    Dr Muhammad Hanif

  52. Making organoruthenium complexes of 8-hydroxyquinolines more hydrophilic: impact of a novel l-phenylalanine-derived arene ligand on the biological activity

    Article • Dalton Transactions, January 2018, Royal Society of Chemistry

    Dr Muhammad Hanif

  53. Organometallics in Cancer Treatment—Non-conventional Structures and Modes of Action

    Article • January 2018, Elsevier

    Dr Muhammad Hanif

  54. Anticancer Ru( η 6 - p -cymene) complexes of 2-pyridinecarbothioamides: A structure–activity relationship study

    Article • Journal of Inorganic Biochemistry, December 2017, Elsevier

    Dr Muhammad Hanif

  55. Ruthenium Anticancer Agents En Route to the Tumor

    Article • November 2017, Wiley

    Dr Muhammad Hanif

  56. Aspirin-inspired organometallic compounds: Structural characterization and cytotoxicity

    Article • Journal of Organometallic Chemistry, June 2017, Elsevier

    Dr Muhammad Hanif

  57. Back Cover: Functionalization of Ruthenium(II)(η6 -p -cymene)(3-hydroxy-2-pyridone) Complexes with (Thio)Morpholine: Synthesis and Bioanalytical Studies (ChemPlusChem 6/2017)

    Article • ChemPlusChem, April 2017, Wiley

    Dr Muhammad Hanif

  58. Functionalization of Ruthenium(II)(η6 -p -cymene)(3-hydroxy-2-pyridone) Complexes with (Thio)Morpholine: Synthesis and Bioanalytical Studies

    Article • ChemPlusChem, April 2017, Wiley

    Dr Muhammad Hanif

  59. Anti-Inflammatory Oxicams as Multi-donor Ligand Systems: pH- and Solvent-Dependent Coordination Modes of Meloxicam and Piroxicam to Ru and Os

    Article • Chemistry - A European Journal, March 2017, Wiley

    Dr Muhammad Hanif

  60. Ruthenium Anticancer Agents-From Cisplatin Analogues to Rational Drug Design

    Article • March 2017, Wiley

    Dr Muhammad Hanif

  61. Synthesis, X-ray structure, spectroscopic (IR, NMR) analysis and DFT modeling of a new polymeric Zinc(II) complex of cystamine, [Zn(Cym-Cym)Cl2]

    Article • Polyhedron, January 2017, Elsevier

    Dr Muhammad Hanif

  62. Cationic Ru(η6-p-cymene) Complexes of 3-Hydroxy-4-pyr(id)ones - Lipophilic Triphenylphosphine as Co-Ligand Is Key to Highly Stable and Cytotoxic Anticancer Agents

    Article • European Journal of Inorganic Chemistry, December 2016, Wiley

    Dr Muhammad Hanif

  63. Anticancer activity of Ru- and Os(arene) compounds of a maleimide-functionalized bioactive pyridinecarbothioamide ligand

    Article • Journal of Inorganic Biochemistry, December 2016, Elsevier

    Dr Muhammad Hanif

  64. Pt(II) pyridinium amidate (PYA) complexes: Preparation and in vitro anticancer activity studies

    Article • Inorganica Chimica Acta, August 2016, Elsevier

    Dr Muhammad Hanif, Professor Leonard James Wright

  65. N-(4-Benzoylphenyl)pyridine-2-carbothioamide

    Article • IUCrData, March 2016, International Union of Crystallography

    Dr. Muhammad Nawaz Tahir, Dr Muhammad Hanif

  66. Metal complexes of benzimidazole derived sulfonamide: Synthesis, molecular structures and antimicrobial activity

    Article • Inorganica Chimica Acta, March 2016, Elsevier

    Dr Muhammad Hanif

  67. RuII(η6-p-cymene) Complexes of Bioactive 1,2-Benzothiazines: Protein Binding vs. Antitumor Activity

    Article • European Journal of Inorganic Chemistry, February 2016, Wiley

    Dr Muhammad Hanif

  68. Half-Sandwich Ruthenium(II) Biotin Conjugates as Biological Vectors to Cancer Cells

    Article • Chemistry - A European Journal, February 2015, Wiley

    Dr Muhammad Hanif

  69. Traditional Uses, Phytochemistry, and Pharmacology ofOlea europaea(Olive)

    Article • Evidence-based Complementary and Alternative Medicine, January 2015, Hindawi Publishing Corporation

    Mr. Muhammad Ali Hashmi, Dr Muhammad Hanif, Professor Dr Shagufta Perveen CChem, FRSC, MACS

  70. Synthesis and characterization of silver(I) complexes of thioureas and thiocyanate: crystal structure of polymeric (1,3-diazinane-2-thione)thiocyanato silver(I)

    Article • Zeitschrift für Naturforschung B, January 2015, De Gruyter

    Dr Muhammad Hanif

  71. Organoruthenium and Osmium Anticancer Complexes Bearing a Maleimide Functional Group: Reactivity to Cysteine, Stability, and Cytotoxicity

    Article • ChemPlusChem, December 2014, Wiley

    Dr Muhammad Hanif

  72. Development of anticancer agents: wizardry with osmium

    Article • Drug Discovery Today, October 2014, Elsevier

    Dr Muhammad Hanif

  73. Anticancer Ruthenium(η6-p-cymene) Complexes of Nonsteroidal Anti-inflammatory Drug Derivatives

    Article • Organometallics, September 2014, American Chemical Society (ACS)

    Dr Muhammad Hanif

  74. Aromaticities of azines relative to benzene; a theoretical approach through the dimethyldihydropyrene probe

    Article • Journal of Physical Organic Chemistry, September 2014, Wiley

    Dr Muhammad Hanif

  75. RutheniumII(η6-arene) Complexes of Thiourea Derivatives: Synthesis, Characterization and Urease Inhibition

    Article • Molecules, June 2014, MDPI AG

    Professor Jamshed Iqbal, Dr Muhammad Hanif

  76. Extraction of Pb(II) from water samples by ionic liquid-modified silica sorbents

    Article • Desalination and Water Treatment, June 2014, Taylor & Francis

    Dr Muhammad Hanif

  77. Aromaticity of azines through dyotropic double hydrogen transfer reaction

    Article • Journal of Molecular Modeling, June 2014, Springer Science + Business Media

    Dr Muhammad Hanif

  78. Copper Complexes of Bioactive Ligands with Superoxide Dismutase Activity

    Article • Mini-Reviews in Medicinal Chemistry, October 2013, Bentham Science Publishers

    Mr. Muhammad Ali Hashmi, Dr Muhammad Hanif

  79. Solution equilibrium studies on anticancer ruthenium(II)–η6-p-cymene complexes of 3-hydroxy-2(1H)-pyridones

    Article • Journal of Organometallic Chemistry, June 2013, Elsevier

    Dr Muhammad Hanif

  80. Theoretical insight of polypyrrole ammonia gas sensor

    Article • Synthetic Metals, May 2013, Elsevier

    Dr Muhammad Hanif

  81. Novel metal(ii) arene 2-pyridinecarbothioamides: a rationale to orally active organometallic anticancer agents

    Article • Chemical Science, January 2013, Royal Society of Chemistry

    Dr Muhammad Hanif

  82. Influence of the π-coordinated arene on the anticancer activity of ruthenium(II) carbohydrate organometallic complexes

    Article • Frontiers in Chemistry, January 2013, Frontiers

    Dr Muhammad Hanif

  83. Organometallic Ruthenium and Osmium Compounds of Pyridin-2- and -4-ones as Potential Anticancer Agents

    Article • Chemistry & Biodiversity, September 2012, Wiley

    Dr Muhammad Hanif

  84. Biomolecule binding vs. anticancer activity: Reactions of Ru(arene)[(thio)pyr-(id)one] compounds with amino acids and proteins

    Article • Journal of Inorganic Biochemistry, March 2012, Elsevier

    Dr Muhammad Hanif

  85. Maleimide-functionalised organoruthenium anticancer agents and their binding to thiol-containing biomolecules

    Article • Chemical Communications, January 2012, Royal Society of Chemistry

    Dr Muhammad Hanif

  86. Synthesis of [RuII(η6-p-cymene)(PPh3)(L)Cl]PF6 complexes with carbohydrate-derived phosphites, imidazole or indazole co-ligands

    Article • Inorganica Chimica Acta, January 2012, Elsevier

    Dr Muhammad Hanif

  87. Pyrone derivatives and metals: From natural products to metal-based drugs

    Article • Journal of Organometallic Chemistry, March 2011, Elsevier

    Dr Muhammad Hanif

  88. From hydrolytically labile to hydrolytically stable RuII–arene anticancer complexes with carbohydrate-derived co-ligands

    Article • Journal of Inorganic Biochemistry, February 2011, Elsevier

    Dr Muhammad Hanif

  89. Is the Reactivity of M(II)−Arene Complexes of 3-Hydroxy-2(1H)-pyridones to Biomolecules the Anticancer Activity Determining Parameter?

    Article • Inorganic Chemistry, September 2010, American Chemical Society (ACS)

    Dr Muhammad Hanif

  90. Osmium(ii)–versus ruthenium(ii)–arene carbohydrate-based anticancer compounds: similarities and differences

    Article • Dalton Transactions, January 2010, Royal Society of Chemistry

    Dr Muhammad Hanif

  91. Influence of the Arene Ligand and the Leaving Group on the Anticancer Activity of (Thio)maltol Ruthenium(II)?(η6-Arene) Complexes

    Article • Australian Journal of Chemistry, January 2010, CSIRO Publishing

    Dr Muhammad Hanif

  92. Silver(I) Complexation with Glutathione in the Presence of Tetramethylthiourea

    Article • Synthesis and Reactivity in Inorganic Metal-Organic and Nano-Metal Chemistry, March 2009, Taylor & Francis

    Dr Muhammad Hanif

  93. In Vitro Anticancer Activity and Biologically Relevant Metabolization of Organometallic Ruthenium Complexes with Carbohydrate-Based Ligands

    Article • Chemistry - A European Journal, August 2008, Wiley

    Dr Muhammad Hanif

  94. Bis(cyanido-κC)(ethane-1,2-diamine-κ2N,N′)silver(II)

    Article • Acta Crystallographica Section E Structure Reports Online, September 2007, International Union of Crystallography

    Professor Emerita Helen Stoeckli-Evans, Dr Muhammad Hanif

  95. Poly[bis(μ2-cyanido)-κ2C:N;κ2N:C-(μ2-N,N,N′,N′-tetramethylthiourea-κ2S:S)disilver(I)]

    Article • Acta Crystallographica Section E Structure Reports Online, September 2007, International Union of Crystallography

    Professor Emerita Helen Stoeckli-Evans, Dr Muhammad Hanif